Article info
PDFPractice
Original article
SELDI-TOF derived serum biomarkers failed to differentiate between patients with beryllium sensitisation and patients with chronic beryllium disease
- Correspondence to Brian C Tooker, University of Colorado Denver, Allergy and Clinical Immunology, Building: RC2, Mail Stop: B164, 12700 E. 19th Ave, Aurora, CO 80045, USA; brian.tooker{at}ucdenver.edu
Citation
SELDI-TOF derived serum biomarkers failed to differentiate between patients with beryllium sensitisation and patients with chronic beryllium disease
Publication history
- Accepted December 16, 2010
- First published January 27, 2011.
Online issue publication
April 27, 2016
Article Versions
- Previous version (27 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.